LANTERN PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.3 USD | +0.80% |
|
+0.48% | +47.20% |
| 05-29 | Transcript : Lantern Pharma Inc. - Special Call | |
| 05-24 | Lantern Pharma Files $150 Million Mixed Shelf | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 67.24M | - | - | - | - | - | |
| 56.65B | - | |||||
| 39.44B | ||||||
| 39.03B | ||||||
| 26.86B | ||||||
| 26.75B |
- Stock Market
- Equities
- LTRN Stock
- Charts Lantern Pharma Inc.
- Sector Chart